KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Accumulated Expenses: 2015-2025

Historic Accumulated Expenses for Medpace Holdings (MEDP) over the last 9 years, with Sep 2025 value amounting to $368.7 million.

  • Medpace Holdings' Accumulated Expenses rose 20.16% to $368.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $368.7 million, marking a year-over-year increase of 20.16%. This contributed to the annual value of $307.8 million for FY2024, which is 5.07% up from last year.
  • According to the latest figures from Q3 2025, Medpace Holdings' Accumulated Expenses is $368.7 million, which was up 13.98% from $323.5 million recorded in Q2 2025.
  • Medpace Holdings' Accumulated Expenses' 5-year high stood at $368.7 million during Q3 2025, with a 5-year trough of $123.6 million in Q1 2021.
  • Its 3-year average for Accumulated Expenses is $286.1 million, with a median of $292.7 million in 2024.
  • Data for Medpace Holdings' Accumulated Expenses shows a peak YoY skyrocketed of 41.67% (in 2021) over the last 5 years.
  • Medpace Holdings' Accumulated Expenses (Quarterly) stood at $159.3 million in 2021, then spiked by 31.92% to $210.1 million in 2022, then skyrocketed by 39.42% to $293.0 million in 2023, then grew by 5.07% to $307.8 million in 2024, then grew by 20.16% to $368.7 million in 2025.
  • Its Accumulated Expenses was $368.7 million in Q3 2025, compared to $323.5 million in Q2 2025 and $286.1 million in Q1 2025.